Skip to main content
Log in

CASE REPORT: Efficacy of Early Immunosuppressive Therapy in a Child with Carbamazepine-Associated Vanishing Bile Duct and Stevens-Johnson Syndromes

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. Desmet VJ: Vanishing bile duct disorders. In JL Boyer, RK Ockner, (eds). Progress in Liver Diseases, Vol. X. Philadelphia, WB Saunders, pp 89–121, 1992

    Google Scholar 

  2. Desmet VJ: Vanishing bile duct syndrome in drug-induced liver disease. J Hepatol 26(suppl 1):31–35, 1997

    Google Scholar 

  3. Patterson R, Tripathi A: Stevens-Johnson syndrome: Getting ready for the year 2000 and beyond. Ann Allergy, Asthma Immunol 83:339–340, 1999

    Google Scholar 

  4. Burra P, Elias E: Vanishing bile duct syndrome. Br J Surg 79:604–605, 1992

    Google Scholar 

  5. Degott C, Feldmann G., Larrey D, Durand-Schneider AM, Grange D, Machayekhi JP, Moreau A, Potet F, Benhamou JP: Drug-induced prolonged cholestasis in adults:a histological semiquantitative study demonstrating progressive ductopenia. Hepatology 15:244–251, 1992

    Google Scholar 

  6. Srivastava M, Perez-Atayde A, Jonas M: Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child. Gastroenterology 115:743–746, 1998

    Google Scholar 

  7. Forbes G, Jeffrey G, Shilkin K, Reed W: Carbamazapine hepatotoxicity: Another cause of the vanishing bile duct syndrome. Gastroenterology 102:1385–1388, 1992

    Google Scholar 

  8. De Galoscy C, Horsmans Y, Rahier J, Geubel A: Vanishing bile duct syndrome occurring after carbamazepine administration: A second case report. J Clin Gastroenterol 19:269–271, 1994

    Google Scholar 

  9. Pirmohamed M, Kitteringham NR, Breckenbridge AM, Park BK: Detection of an autoantibody directed against human liver microsomal protein in a patient with caarbamazepine hypersensitivity. Br J Clin Pharmacol 33:183–186, 1992

    Google Scholar 

  10. Thomson AW, Satoh S, Nussler AK, Tamura K, Woo J, Gavaler J, van Theil DH: Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes. Clin Exp Immunol 95:83–90, 1994

    Google Scholar 

  11. Inachi S, Mizutani H, Shimizu M: Epidermal apoptotic cell death in erythema multiform and Stevens-Johnson syndrome. Arch Dermatol 133:845–849, 1997

    Google Scholar 

  12. Sayama K, Watanabe Y, Tohyam, Miki Y: Localization of perforin vesicles and erythema multiforme. Dermatology 188:305–309, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garcia, M., Mhanna, M.J., Chung-Park, MJ. et al. CASE REPORT: Efficacy of Early Immunosuppressive Therapy in a Child with Carbamazepine-Associated Vanishing Bile Duct and Stevens-Johnson Syndromes. Dig Dis Sci 47, 177–182 (2002). https://doi.org/10.1023/A:1013296310944

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1013296310944

Navigation